Internal Medicine, Allergy & Immunology · New York, NY
NPI
1134147937
Since 2006
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5 East 98th Street
New York, NY, 10029
Phone (212) 241-0764
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,401
271 services
Medicare patients, 2024
71
Average age 72
Drug cost, 2024
$2.3M
235 prescriptions
Company payments, 2025
$20K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paula J Busse was code 99213 (office e&m - established), 25 times for 24 patients. In total Paula J Busse billed 271 services in 16 codes, and Medicare paid $6,401.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 25 | 24 | $69.15 | $1,729 |
| 99203 Office E&M - New | Office | 19 | 19 | $72.46 | $1,377 |
By year: 2022 $6,897 for 108 services; 2023 $12K for 355 services; 2024 $6,401 for 271 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 17 | $8.40 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Paula J Busse prescribed most often to Medicare patients was Fluticasone Propionate, with 34 prescriptions and refills. In total Paula J Busse wrote 235 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 34 | 59 | 11 | $333 |
| Takhzyro Lanadelumab-Flyo | 33 | 33 | Under 11 | $1.4M |
| Azelastine Hcl Generic | 26 | 36 | Under 11 | $660 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 24 | 24 | Under 11 | $447 |
| Levocetirizine Dihydrochloride Generic | 20 | 38 | Under 11 | $320 |
| Icatibant Icatibant Acetate | 17 | 17 | Under 11 | $137K |
| Epinephrine Generic | 16 | 20 | 11 | $2,488 |
| Xolair Omalizumab | 11 | 11 | Under 11 | $16K |
Brand drugs: 99 claims; generic drugs: 136 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paula J Busse $20K ($20K in general payments such as food, travel and fees) from 4 companies. The largest payer was CSL Behring with $10K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.